Literature DB >> 14521801

Surgical staging of cancer: impact on prognosis and potential for bias in clinical trials.

Maurie Markman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14521801     DOI： 10.1007/s11912-003-0001-2

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  12 in total

1.  Lymph node dissection: is it diagnostic or therapeutic?

Authors:  Elin R Sigurdson
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

2.  Second thoughts about second-look laparotomy in advanced ovarian cancer.

Authors:  J B Friedman; N S Weiss
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

Review 3.  Cancer of the ovary.

Authors:  S A Cannistra
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

4.  Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials.

Authors:  R C Young; L A Walton; S S Ellenberg; H D Homesley; G D Wilbanks; D G Decker; A Miller; R Park; F Major
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

5.  Second-look laparotomy after chemotherapy in the management of ovarian malignancy.

Authors:  L R Smirz; F B Stehman; T M Ulbright; G P Sutton; C E Ehrlich
Journal:  Am J Obstet Gynecol       Date:  1985-07-15       Impact factor: 8.661

6.  A review of second-look laparotomy for ovarian cancer.

Authors:  J M Cain; P E Saigo; V K Pierce; D G Clark; W B Jones; D H Smith; T B Hakes; M Ochoa; J L Lewis
Journal:  Gynecol Oncol       Date:  1986-01       Impact factor: 5.482

7.  Staging laparotomy in early ovarian cancer.

Authors:  R C Young; D G Decker; J T Wharton; M S Piver; W F Sindelar; B K Edwards; J P Smith
Journal:  JAMA       Date:  1983-12-09       Impact factor: 56.272

8.  International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Authors:  J Baptist Trimbos; Mahesh Parmar; Ignace Vergote; David Guthrie; Giorgio Bolis; Nicoletta Colombo; Jan B Vermorken; Valter Torri; Constantino Mangioni; Sergio Pecorelli; Andrea Lissoni; Ann Marie Swart
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506

9.  Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.

Authors:  J Baptist Trimbos; Ignace Vergote; Giorgio Bolis; Jan B Vermorken; Constantino Mangioni; Caterina Madronal; Massimo Franchi; Saverio Tateo; Gerardo Zanetta; Giovanna Scarfone; Livia Giurgea; Petra Timmers; Corneel Coens; Sergio Pecorelli
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506

10.  International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer.

Authors:  Nicoletta Colombo; David Guthrie; Stefania Chiari; Mahesh Parmar; Wendi Qian; Ann Marie Swart; Valter Torri; Christopher Williams; Andrea Lissoni; Cristina Bonazzi
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506
View more
  2 in total

1.  Improvement of T stage precision by integration of surgical and pathological staging in radically resected stage pT3-pT4b gastric cancer.

Authors:  Hong-Hu Wang; Kai Li; Hao Xu; Zhe Sun; Zhen-Ning Wang; Hui-Mian Xu
Journal:  Oncotarget       Date:  2017-07-11

2.  The integration of macroscopic tumor invasion of adjacent organs into TNM staging system for colorectal cancer.

Authors:  Ji-Wang Liang; Peng Gao; Zhen-Ning Wang; Yong-Xi Song; Ying-Ying Xu; Mei-Xian Wang; Yu-Lan Dong; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.